Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Fexuprazan by Daewoong for Helicobacter pylori Infections: Likelihood of Approval
Fexuprazan is under clinical development by Daewoong and currently in Phase II for Helicobacter pylori Infections. According to GlobalData, Phase...